Cargando…

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia

Negative symptoms (e.g., decreased spontaneity, social withdrawal, blunt affect) and disturbances of cognitive function (e.g., several types of memory, attention, processing speed, executive function, fluency) provide a major determinant of long-term outcome in patients with schizophrenia. Specifica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumiyoshi, Tomiki, Kunugi, Hiroshi, Nakagome, Kazuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255483/ https://www.ncbi.nlm.nih.gov/pubmed/25538549 http://dx.doi.org/10.3389/fnins.2014.00395

Ejemplares similares

Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018)

Time estimation in a case of Tourette's syndrome: Effect of antipsychotic medications
por: Inagawa, Takuma, et al.
Publicado: (2020)

Augmentation therapy with serotonin(1A) receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
por: Yamada, Risa, et al.
Publicado: (2023)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence
por: Stuchlik, Ales, et al.
Publicado: (2014)

CENTRAL DOPAMINE AND SEROTONIN TURNOVER IN SCHIZOPHRENIA
por: Pandey, R.S., et al.
Publicado: (1987)

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
por: Martel, Jean Claude, et al.
Publicado: (2020)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2019)

Psychoneurobiology Research and Personalized Treatment of Schizophrenia
por: Sumiyoshi, Tomiki
Publicado: (2021)

The role of serotonin 5-HT(2A) receptors in memory and cognition
por: Zhang, Gongliang, et al.
Publicado: (2015)

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
por: Coyle, Joseph T., et al.
Publicado: (2010)

New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function
por: Jeon, Won Je, et al.
Publicado: (2015)

Dopamine D(3) Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony
por: Lemercier, Clément E., et al.
Publicado: (2016)

Serotonin 5-HT(2C) Receptor Activation Suppresses Binge Intake and the Reinforcing and Motivational Properties of High-Fat Food
por: Price, Amanda E., et al.
Publicado: (2018)

Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs
por: Ohi, Kazutaka, et al.
Publicado: (2018)

Electrophysiological Evidence in Schizophrenia in Relation to Treatment Response
por: Sueyoshi, Kazuki, et al.
Publicado: (2018)

LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain
por: Li, Nannan, et al.
Publicado: (2019)

Tandospirone, a 5-HT(1A) partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia
por: Uehara, Takashi, et al.
Publicado: (2014)

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017)

Effect of 5-HT(1A) Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
por: Yamada, Risa, et al.
Publicado: (2023)

Amphetamine-induced prolonged disturbances in tissue levels of dopamine and serotonin in the rat brain
por: Taracha, Ewa, et al.
Publicado: (2023)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

Voltage-Dependent Dopamine Potency at D(1)-Like Dopamine Receptors
por: Ågren, Richard, et al.
Publicado: (2020)

Role of nucleus accumbens dopamine 2 receptors in motivating cocaine use in male and female rats prior to and following the development of an addiction-like phenotype
por: Towers, Eleanor Blair, et al.
Publicado: (2023)

Impaired prefrontal activity to regulate the intrinsic motivation-action link in schizophrenia
por: Takeda, Kazuyoshi, et al.
Publicado: (2017)

Serotonin 2a Receptor and Serotonin 1a Receptor Interact Within the Medial Prefrontal Cortex During Recognition Memory in Mice
por: Morici, Juan F., et al.
Publicado: (2015)

Association of fronto-temporal function with cognitive ability in schizophrenia
por: Pu, Shenghong, et al.
Publicado: (2017)

Positive symptoms and time perception in schizophrenia: A meta-analysis
por: Ueda, Natsuki, et al.
Publicado: (2018)

Verbal Memory Impairment in Patients with Subsyndromal Bipolar Disorder
por: Sumiyoshi, Tomiki, et al.
Publicado: (2017)

Enhancement stimulants: perceived motivational and cognitive advantages
por: Ilieva, Irena P., et al.
Publicado: (2013)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
por: Burström, Viktor, et al.
Publicado: (2023)

Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version
por: Higuchi, Yuko, et al.
Publicado: (2017)

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
por: Gratz, Michael J, et al.
Publicado: (2018)

The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
por: Wu, Tzu-Hua, et al.
Publicado: (2021)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
por: Hoshino, Yuki, et al.
Publicado: (2022)

Electrophysiological and Neuropsychological Predictors of Conversion to Schizophrenia in At-Risk Subjects
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to  Biomarkers
por: Yamada, Yuji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g99ak5b74hf1cn9na35345v5tg